111 related articles for article (PubMed ID: 8338006)
1. Evaluation of the need to modify antiarrhythmic therapy because of drug intolerance or inefficacy in patients evaluated by electrophysiology study.
Ujhelyi MR; Fisher JR; Chow MS; Kluger J
Am Heart J; 1993 Aug; 126(2):352-9. PubMed ID: 8338006
[TBL] [Abstract][Full Text] [Related]
2. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
[TBL] [Abstract][Full Text] [Related]
4. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents.
Constantin L; Martins JB; Kienzle MG; Brownstein SL; McCue ML; Hopson RC
Pacing Clin Electrophysiol; 1989 May; 12(5):776-83. PubMed ID: 2471163
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
Klein RC
Eur Heart J; 1993 Nov; 14 Suppl H():78-84. PubMed ID: 8293756
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
8. Effect of high-current stimulation in patients with sustained ventricular tachycardia rendered noninducible by antiarrhythmic drugs.
Hook BG; Marchlinski FE; Josephson ME; Buxton AE
Am J Cardiol; 1992 Sep; 70(7):752-7. PubMed ID: 1519525
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups.
Poole JE; Mathisen TL; Kudenchuk PJ; McAnulty JH; Swerdlow CD; Bardy GH; Greene HL
J Am Coll Cardiol; 1990 Sep; 16(3):657-65. PubMed ID: 2387939
[TBL] [Abstract][Full Text] [Related]
11. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients.
Chen X; Shenasa M; Borggrefe M; Block M; Hindricks G; Martinez-Rubio A; Haverkamp W; Willems S; Böcker D; Mäkijärvi M
Eur Heart J; 1994 Jan; 15(1):76-82. PubMed ID: 8174587
[TBL] [Abstract][Full Text] [Related]
12. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
Reiffel JA
Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
Niwano S; Yamaura M; Yoshizawa N; Moriguchi M; Kitano Y; Aizawa Y; Izumi T
Jpn Circ J; 1999 Sep; 63(9):674-80. PubMed ID: 10496481
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease.
Friehling TD; Lipshutz H; Marinchak RA; Stohler JL; Kowey PR
Am J Cardiol; 1990 Jun; 65(20):1328-33. PubMed ID: 2343820
[TBL] [Abstract][Full Text] [Related]
15. Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group.
Kowey PR; Waxman HL; Greenspon A; Greenberg R; Poll D; Kutalek S; Gessman L; Muenz L
Am J Cardiol; 1990 Mar; 65(9):594-8. PubMed ID: 2309629
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias.
Brachmann J; Schöls W; Beyer T; Montero M; Enders B; Kübler W
Eur Heart J; 1993 Nov; 14 Suppl H():85-7. PubMed ID: 8293757
[TBL] [Abstract][Full Text] [Related]
18. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of ventricular tachycardia suppression by antiarrhythmic drug therapy during serial electrophysiologic testing in coronary artery disease.
Garan H; Stavens CS; McGovern B; Kelly E; Ruskin JN
Am J Cardiol; 1986 Nov; 58(10):977-80. PubMed ID: 3776854
[TBL] [Abstract][Full Text] [Related]
20. Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.
Reiffel JA; Reiter MJ; Freedman RA; Mann D; Huang SK; Hahn E; Hartz V; Mason J;
Prog Cardiovasc Dis; 1996; 38(5):359-70. PubMed ID: 8604440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
